Ryan A Murr

Co-chair, global life sciences practice, Ryan focuses on representing operating companies and investors in the biotechnology, pharmaceutical, diagnostics and medical device industries in connection with securities offerings, corporate governance matters and business combination transactions. He serves as principal outside counsel for publicly-traded companies and venture-backed companies, advising management teams and boards of directors on general corporate matters, securities offerings, SEC reporting, corporate governance, royalty financings and mergers & acquisitions. He also advises investment funds (private equity funds, hedge funds, venture funds and royalty buyout funds) in connection with investments in life sciences companies and assets.